康缘药业
(600557)
| 流通市值：84.41亿 | | | 总市值：84.41亿 |
| 流通股本：5.66亿 | | | 总股本：5.66亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,157,376,554.5 | 2,061,690,182.53 | 2,094,172,093.81 | 2,195,076,101.94 |
| 交易性金融资产 | - | 20,000,000 | 50,000,000 | 40,000,000 |
| 应收票据及应收账款 | 487,831,564.21 | 507,448,630.84 | 525,924,489.91 | 525,920,722.65 |
| 应收账款 | 487,831,564.21 | 507,448,630.84 | 525,924,489.91 | 525,920,722.65 |
| 应收款项融资 | 143,074,828.53 | 316,772,248.88 | 219,347,096.58 | 174,623,132.05 |
| 预付款项 | 20,914,537.11 | 47,876,096.9 | 35,194,399.24 | 26,562,911.57 |
| 其他应收款合计 | 3,298,830.7 | 3,785,236.33 | 4,416,279.65 | 6,325,142.86 |
| 存货 | 445,231,555.04 | 453,009,370.61 | 515,373,930.8 | 540,269,821.74 |
| 其他流动资产 | 43,905,538.38 | 38,805,477.62 | 71,315,315.11 | 87,127,580.55 |
| 流动资产合计 | 3,301,633,408.47 | 3,449,387,243.71 | 3,515,743,605.1 | 3,595,905,413.36 |
| 非流动资产: | | | | |
| 长期股权投资 | 4,136,930.02 | 4,136,930.02 | 4,126,567.57 | 4,126,567.57 |
| 其他非流动金融资产 | 7,195,658.61 | 8,195,658.61 | 8,195,658.61 | 11,210,107.4 |
| 固定资产 | 2,195,180,961.17 | 2,235,797,611.53 | 2,263,344,673.05 | 2,278,707,657.81 |
| 在建工程 | 694,601,898.81 | 596,698,783.34 | 533,396,074.51 | 472,805,540.4 |
| 使用权资产 | 1,228,657.98 | 1,294,478.94 | - | - |
| 无形资产 | 203,624,875.41 | 208,162,623.7 | 166,462,108.32 | 171,460,213.98 |
| 开发支出 | 190,945,395.7 | 189,461,499.93 | 188,334,900.9 | 187,992,816.15 |
| 商誉 | 58,988,858.14 | 58,988,858.14 | 58,988,858.14 | 58,988,858.14 |
| 长期待摊费用 | 12,013,718.05 | 13,292,450.26 | 14,571,182.48 | 15,849,914.7 |
| 递延所得税资产 | 47,707,328.69 | 49,770,477.24 | 46,295,367.01 | 45,313,093.18 |
| 其他非流动资产 | 22,992,658.5 | 18,199,936.13 | 85,319,097.28 | 64,402,198.69 |
| 非流动资产合计 | 3,438,616,941.08 | 3,383,999,307.84 | 3,369,034,487.87 | 3,310,856,968.02 |
| 资产总计 | 6,740,250,349.55 | 6,833,386,551.55 | 6,884,778,092.97 | 6,906,762,381.38 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 210,331,077.22 | 228,762,188.71 | 257,872,794.67 | 226,872,983.31 |
| 其中：应付票据 | 42,971,261.41 | 109,177,870.35 | 103,905,270.62 | 37,698,661.68 |
| 应付账款 | 167,359,815.81 | 119,584,318.36 | 153,967,524.05 | 189,174,321.63 |
| 合同负债 | 22,825,314 | 22,739,447.22 | 24,292,139.61 | 25,455,210.81 |
| 应付职工薪酬 | 20,321,249.96 | 13,654,368.1 | 7,817,858.76 | 29,058,146.1 |
| 应交税费 | 60,648,149.02 | 51,443,556.75 | 35,421,632.45 | 34,988,075.94 |
| 其他应付款合计 | 1,334,835,769.66 | 1,470,948,866.32 | 1,601,079,799.21 | 1,725,154,638.53 |
| 一年内到期的非流动负债 | 248,351.71 | 246,203.71 | - | - |
| 其他流动负债 | 2,967,290.83 | 2,956,128.14 | 3,150,549.36 | 2,951,853.2 |
| 流动负债合计 | 1,652,177,202.4 | 1,790,750,758.95 | 1,929,634,774.06 | 2,044,480,907.89 |
| 非流动负债: | | | | |
| 租赁负债 | 798,436.48 | 791,530.72 | - | - |
| 长期应付款 | 1,925,490 | 1,925,490 | 1,925,490 | 1,925,490 |
| 递延收益 | 172,561,838.71 | 186,119,910.17 | 162,574,952.29 | 155,265,492.05 |
| 非流动负债合计 | 175,285,765.19 | 188,836,930.89 | 164,500,442.29 | 157,190,982.05 |
| 负债合计 | 1,827,462,967.59 | 1,979,587,689.84 | 2,094,135,216.35 | 2,201,671,889.94 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 566,158,806 | 566,158,806 | 569,459,106 | 581,797,452 |
| 减:库存股 | - | - | 26,068,966 | 211,978,588.9 |
| 盈余公积 | - | - | - | 76,254,078.46 |
| 未分配利润 | 4,148,058,755.42 | 4,090,786,362.31 | 4,054,598,654.86 | 4,068,502,873.09 |
| 归属于母公司股东权益合计 | 4,714,217,561.42 | 4,656,945,168.31 | 4,597,988,794.86 | 4,514,575,814.65 |
| 少数股东权益 | 198,569,820.54 | 196,853,693.4 | 192,654,081.76 | 190,514,676.79 |
| 股东权益合计 | 4,912,787,381.96 | 4,853,798,861.71 | 4,790,642,876.62 | 4,705,090,491.44 |
| 负债和股东权益合计 | 6,740,250,349.55 | 6,833,386,551.55 | 6,884,778,092.97 | 6,906,762,381.38 |
| 公告日期 | 2025-10-31 | 2025-08-28 | 2025-04-30 | 2025-04-03 |
| 审计意见(境内) | | | | 标准无保留意见 |